Peptides from the Variable Region of Specific Antibodies Are Shared among Lung Cancer Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096029
- By:
- Publication type:
- Article
Works matching AU Vernhout, Rene
Results: 5
1
2
The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac032
- By:
- Publication type:
- Article
3
Feasibility, SAR Distribution, and Clinical Outcome upon Reirradiation and Deep Hyperthermia Using the Hypercollar3D in Head and Neck Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6149, doi. 10.3390/cancers13236149
- By:
- Publication type:
- Article
4
Training Medical Specialists to Communicate Better with Patients with Medically Unexplained Physical Symptoms (MUPS). A Randomized, Controlled Trial.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0138342
- By:
- Publication type:
- Article
5
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab--a report from the BELOB trial.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 6, p. 853, doi. 10.1093/neuonc/now311
- By:
- Publication type:
- Article